- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02856958
Acute Nerve Decompression Versus Non-operative Treatment for Peroneal Nerve Palsy Following Primary Total Knee Arthroplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Peroneal nerve palsy after TKA has been reported in the literature to be 0.3% to 1.5%, although it can be as high as 9.5%. Several risk factors have been described: preoperative valgus deformity and flexion contracture, prolonged intraoperative use of a tourniquet, use of epidural anesthesia, and rheumatoid arthritis. Peroneal palsy is rarely diagnosed on postoperative day 0, but in more than 85% of cases, it presents prior to postoperative day 4.Initial treatment should include flexing the knee, removing any compressive bandages, and discontinuing epidural anesthesia. When there are residual deficits, supportive measures are initiated, including application of an ankle-foot orthosis and physical therapy to prevent ankle contracture. If there is no clinical recovery by six to twelve weeks, electromyography (EMG) is typically performed. Some clinicians have advocated the use of EMG studies in the acute phase. In cases of incomplete recovery, delayed surgical exploration and decompression of the peroneal nerve is an option that has been reported to improve outcomes. Unfortunately, not all cases respond, even with surgical treatment. In addition, little information is available describing the outcomes of acute surgical decompression for peroneal nerve palsy after total knee arthroplasty.
While there have been retrospective case reports and series that have examined outcomes after delayed peroneal nerve decompression, we are unaware of reports describing acute decompression. Delayed decompression of the peroneal nerve has been associated with the return of nerve function. Krackow et al. reported the results of five patients who underwent delayed surgical decompression for peroneal nerve palsy after total knee arthroplasty at an average of 27.2 months (range, 5-50 months) and found that 100% were able to discontinue use of the ankle-foot orthosis and 80% had full neurological recovery. The patient who had partial return of neurological function did not undergo decompression until almost four years postoperatively. Mont et al. found that, in patients who underwent surgical peroneal nerve decompression two to sixty months following total knee arthroplasty, 97% reported functional and subjective improvements at a mean of three years post-decompression and were able to discontinue use of the ankle-foot orthosis. Only 33% of the patients who were managed nonoperatively reported improvement in functional and subjective outcomes.
Therefore, in 33% of the patients, an acute decompression would not have been necessary, but in the other 67%, it may have been beneficial. In both studies, patients underwent a trial of nonoperative treatment, and no patient underwent a peroneal nerve decompression earlier than two months after the index total knee arthroplasty. Initial experience with two peroneal nerve palsies following TKA has encouraged some institutions to offer acute decompression to all patients who present with peroneal palsy following total knee arthroplasty. This parallels the practice patterns regarding the wrist, where an acute carpal tunnel release is performed to avoid complications when a patient demonstrates carpal tunnel compressive symptoms postoperatively from wrist surgery. While most patients will improve with nonoperative treatment over time, acute decompression may accelerate recovery, which can decrease uncertainty and stress for both the patient and the surgeon. The surgical technique is relatively straightforward; however, the surgeon and patient must consider the risks of a second anesthetic and operation. In previous experiences with both acute and delayed decompression, while direct damage to the nerve itself is rare, fascial bands, hematomas, and local edema are typically identified that contribute to the compression of the peroneal nerve. Therefore, while nonoperative treatment would possibly result in a return of nerve function once the hematoma resorbed and edema decreased, there may still be some residual dysfunction from the time period of nerve compression and thickened fascial bands around the nerve. Additional study of acute decompression is warranted to understand if it offers both short and long-term advantages over nonoperative treatment.
Treatment Groups: Acute Nerve Decompression - patients will initially receive conservative management (flexing the knee, removing any compressive bandages, and discontinuing epidural anesthesia) followed by a peroneal nerve decompression within 1 week of diagnosis of peroneal nerve palsy. Decompression involves surgical intervention in the setting of a sterile operating room. The patient will be provided with multiple options of anesthesia (per discussion with the anesthesia team). The surgical procedure involves an incision at the lateral aspect of the knee, near the proximal fibula at the level of the fibular neck. The peroneal nerve is carefully identified and dissected. Tissue surrounding or impinging the nerve is carefully removed or cut to rid the compressive environment. The nerve is re- examined to ensure there are no additional points of compression/irritation. The soft-tissues and skin are subsequently closed with suture. Nonoperative Treatment - patients will receive conservative management (flexing the knee, removing any compressive bandages, and discontinuing epidural anesthesia) as well as supportive measures (ankle-foot orthosis and physical therapy) for symptoms lasting longer than 6 week. Outcome Measures: Primary Measure - ≥ 3/5 dorsiflexion strength 3 months after surgery/randomization
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Midwest Orthopedics at Rush
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Any patient presenting with peroneal palsy (< 3/5 dorsiflexion) within 3-weeks after primary TKA
Exclusion Criteria:
- Patient's with pre-existing peroneal palsy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Operative
Peroneal nerve decompression
|
|
Active Comparator: Non-operative
Physical therapy
|
Physical therapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Dorsiflexion strength
Time Frame: within 3 months from surgery
|
within 3 months from surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John J Fernandez, MD, Rush University Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16041403
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peroneal Palsy (Foot Drop)
-
Dr Tim ExellPortsmouth Hospitals NHS Trust; Solent NHS TrustRecruitingFoot Drop, Unspecified FootUnited Kingdom
-
Kowloon Hospital, Hong KongChinese University of Hong Kong; Kwong Wah HospitalCompletedStroke | Foot Drop (Acquired)Hong Kong
-
TOPMEDNatural Sciences and Engineering Research Council, Canada; Turbomed Orthotics...Not yet recruiting
-
TOPMEDNatural Sciences and Engineering Research Council, Canada; Turbomed Orthotics...Completed
-
Marmara UniversityCompletedVenous Insufficiency | Foot Drop (Acquired)Turkey
-
Cionic, Inc.Completed
-
Riphah International UniversityCompleted
-
Baltimore VA Medical CenterNot yet recruitingPeripheral Nervous System Diseases | Gait Disorders, Neurologic | Mobility Limitation | Foot Drop
-
Baltimore VA Medical CenterNot yet recruitingPeripheral Nervous System Diseases | Gait Disorders, Neurologic | Mobility Limitation | Foot DropUnited States
Clinical Trials on Nerve decompression
-
Association of Extremity Nerve SurgeonsUnknownDiabetic Polyneuropathy | Diabetic Ulcer of Plantar Aspect of Left Foot | Diabetic Ulcer of Plantar Aspect of Right FootUnited States
-
University of Texas Southwestern Medical CenterCompletedPainful Diabetic NeuropathyUnited States
-
University of ChicagoNorthShore University HealthSystemActive, not recruitingRotator Cuff TearUnited States
-
The Second Hospital of TangshanChinese PLA General HospitalCompleted
-
National Eye Institute (NEI)CompletedIschemic Optic Neuropathy
-
University Medical Centre LjubljanaSlovenian Research AgencyRecruitingPeripheral Nervous System Diseases | Nerve Compression Syndromes | Cubital Tunnel SyndromeSlovenia
-
University Hospital, Strasbourg, FranceTerminatedRobotic DecompressionFrance
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedFailed Back Surgery Syndrome | Postlaminectomy Syndrome | Postdiscectomy Epidural FibrosisUnited States
-
Sohag UniversityNot yet recruiting
-
H. Francis FarhadiSpinal Cord and Brain Injury Research Center (SCOBIRC)RecruitingSpinal Cord Injuries | Acute Traumatic Spinal Cord InjuryUnited States